Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of blaOxa10 Type Beta-lactamase Gene in Carbapenemase Producing Pseudomonas aeruginosa Strains Isolated From Patients in Isfahan

Zeynab Golshani 1 , * and Ali Sharifzadeh 2
Authors Information
1 Department of Microbiology, Young Researchers and elite Club, Falavarjan Branch, Islamic Azad University, Isfahan,IR Iran
2 Department of Microbiology, Faculty of Veterinary Medicine, Shahrekord Branch, Islamic Azad University, Shahrekord, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 01, 2013, 6 (5); e9002
  • Published Online: July 1, 2013
  • Article Type: Research Article
  • Received: November 17, 2012
  • Revised: January 27, 2013
  • Accepted: February 19, 2013
  • DOI: 10.5812/jjm.9002

To Cite: Golshani Z, Sharifzadeh A. Prevalence of blaOxa10 Type Beta-lactamase Gene in Carbapenemase Producing Pseudomonas aeruginosa Strains Isolated From Patients in Isfahan, Jundishapur J Microbiol. 2013 ; 6(5):e9002. doi: 10.5812/jjm.9002.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, et al. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010; 54(3): 1160-4[DOI][PubMed]
  • 2. Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis. 2005; 18(4): 306-13[PubMed]
  • 3. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest. 2001; 119(2 Suppl): 397S-404S[PubMed]
  • 4. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 2003; 47(8): 2385-92[PubMed]
  • 5. Zavascki AP, Carvalhaes CG, Picao RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010; 8(1): 71-93[DOI][PubMed]
  • 6. Yu WL, Chuang YC, Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect. 2006; 39(4): 264-77[PubMed]
  • 7. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010; 23(1): 160-201[DOI][PubMed]
  • 8. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4): 933-51[DOI][PubMed]
  • 9. Nordmann P, Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother. 1998; 42(2): 128-31[PubMed]
  • 10. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10(4): 867-78[PubMed]
  • 11. Mayer MP. A new set of useful cloning and expression vectors derived from pBlueScript. Gene. 1995; 163(1): 41-6[PubMed]
  • 12. al Naiemi N, Duim B, Bart A. A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Med Microbiol. 2006; 55: 1607-8[DOI][PubMed]
  • 13. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006; 43 Suppl 2-56[DOI][PubMed]
  • 14. Rajini Rani DB, Mahadevan A. Plasmid mediated metal and antibiotic resistance in marine Pseudomonas. Biometals. 1992; 5(2): 73-80[PubMed]
  • 15. Padmakrishnan R Amutha, Devi MP Renuga. Studies on multidrug resistant Pseudomonas aeruginosa from pediatric population with special reference to extended spectrum beta lactamase. Indian J Sci Tech. 2009; 2(11): 11-13
  • 16. Peshattiwar Prashant Durwas, Peerapur Basavaraj Virupaksappa, Peerapur Basavaraj Virupakshappa. ESBL and MBL mediated resistance in Pseudomonas aeruginosa: An emerging threat to clinical therapeutics. J Clin Diagn Res. 2011; 5: 1552-4
  • 17. Bert F, Branger C, Lambert-Zechovsky N. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother. 2002; 50(1): 11-8[PubMed]
  • 18. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005; 56(1): 122-7[DOI][PubMed]
  • 19. Suk SE, Yoo JS, Lee JK, Lee KM, Chung GT, Shin ES, et al. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea. J Microbiol Biotechnol. 2007; 17(10): 1733-7[PubMed]
  • 20. Struve C, Forestier C, Krogfelt KA. Application of a novel multi-screening signature-tagged mutagenesis assay for identification of Klebsiella pneumoniae genes essential in colonization and infection. Microbiology. 2003; 149: 167-76[PubMed]
  • 21. Shacheraghi Fereshteh, Shakibaie Mohammad Reza, Noveiri Hanieh. Molecular Identification of ESBL Genes blaGES-blaVEB-blaCTX-M blaOXA-blaOXA-4, blaOXA-10 andblaPER-in Pseudomonas aeruginosa Strains Isolated from Burn Patients by PCR, RFLP and Sequencing Techniques. Int J Bio and Sci. 2010; 6: 3138-142
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments